Background: Given the increasing incidence of papillary thyroid carcinoma despite stable
disease-specific mortality rates, the potential for the disease to reoccur is a key outcome to …

Simple Summary Differentiated thyroid cancer (DTC) is the most common endocrine
malignancy with a high incidence rate in females. The COVID-19 epidemic posed an …

BACKGROUND Recent reports suggest that mutations in the promoter of the gene encoding
telomerase reverse transcriptase (TERT) affect thyroid cancer outcomes. METHODS In all …

Importance Multifocality is common in papillary thyroid carcinoma (PTC), but it is unclear
whether multifocal tumors are associated with tumor recurrence or cancer-specific survival …

The purposes of this study were to investigate the potential roles of long noncoding RNA
(lncRNA) PVT1 in thyroid cancer cell proliferation and to explore their possible mechanisms …

Papillary thyroid carcinoma (PTC) has a high incidence, and its proper treatment remains
challenging. Therefore, identifying PTC progression markers is essential. Here, using 16S …

Although various chemokines have pro-tumorigenic actions in cancers, the effects of
CXCL16 remain controversial. The aim of this study was to investigate the molecular …

Background We aimed to investigate whether the risk of second primary malignancy (SPM)
in patients with thyroid cancer (TC) receiving radioactive iodine (RAI) therapy rises in a …

There is no effective treatment for patients with poorly differentiated papillary thyroid cancer
or anaplastic thyroid cancer (ATC). Anlotinib, a multi-kinase inhibitor, has already shown …

Objective Papillary thyroid microcarcinoma (PTMC) accounts for most of the increase in
thyroid cancer in recent decades. We compared clinical outcomes and surgical …